Central adiposity and decreased heart rate variability in postmenopause: A cross-sectional study

Climacteric

Volumn 16, Issue 5, 2013, Pages 576-583

  Franz, R ^a   Maturana, M A ^a   Magalhaes J A ^a   Moraes, R S ^a   Spritzer, P M ^a,b,c  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c National Institute of Hormones and Women's Health CNPq   (Brazil)

Author keywords

Cardiac Autonomic Modulation; Cardiovascular Risk; Central Obesity; Menopause; Waist Circumference

Indexed keywords

ANDROGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADRENERGIC STIMULATION; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MENTAL STRESS; METABOLIC SYNDROME X; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; PRIORITY JOURNAL; RR INTERVAL; SINGLE BLIND PROCEDURE; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; INSULIN; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; POSTMENOPAUSE; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84884476236     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2012.745123     Document Type: Article

References (67)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 2012; 125: E2-e220
2. Schenck-Gustafsson K. Risk factors for cardiovascular disease in women. Maturitas 2009; 63: 186-90
3. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005; 308: 1583-7
4. Zamboni M, Armellini F, Harris T, et a l. Effects of age on body fat distribution and cardiovascular risk factors in women. Am J Clin Nutr 1997; 66: 111-15
5. You T, Ryan AS, Nicklas BJ. The metabolic syndrome in obese postmenopausal women: Relationship to body composition, visceral fat, and infl ammation. J Clin Endocrinol Metab 2004; 89: 5517-22
6. Donato GB, Fuchs SC, Oppermann K, Bastos C, Spritzer PM. Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waistto-hip ratio. Menopause 2006; 13: 280-5
7. Liu J, Fox CS, Hickson DA, et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: The Jackson Heart Study. J Clin Endocrinol Metab 2010; 95: 5419-26
8. Dube MC, Lemieux S, Piche M E, et a l. The contribution of visceral adiposity and mid-Thigh fat-rich muscle to the metabolic profile in postmenopausal women. Obesity (Silver Spring) 2011; 19: 953-9
9. Smith J D, Borel A L, Nazare J A, et a l. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: Results from the INSPIRE ME IAA study. J Clin Endocrinol Metab 2012; 97: 1517-25
10. Zhu S, Wang Z, Heshka S, et a l. Waist circumference and obesity-Associated risk factors among whites in the Third National Health and Nutrition Examination Survey: Dlinical action thresholds. Am J Clin Nutr 2002; 76: 743-9
11. Pouliot M C, Despres JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73: 460-8
12. Maturana M A, Breda V, Lhullier F, Spritzer P M. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. Metabolism 2008; 57: 961-5
13. Creatsa M, Armeni E, Stamatelopoulos K, et a l. Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women. Metabolism 2012; 61: 193-201
14. Maturana MA, Moreira RM, Spritzer PM. Lipid accumulation product (LAP) is related to androgenicity and cardiovascular risk factors in postmenopausal women. Maturitas 2011; 70: 395-9
15. Rexrode K M, Manson J E, Lee I M, et a l. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 2003; 108: 1688-93
16. Sutton-Tyrrell K, Wildman R P, Matthews K A, et a l. Sexhormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005; 111: 1242-9
17. Kleiger R E, Miller J P, Bigger J T Jr, Moss A J. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59: 256-62
18. Moore R K, Groves D G, Barlow P E, et a l. Heart rate turbulence and death due to cardiac decompensation in patients with chronic heart failure. Eur J Heart Fail 2006; 8: 585-90
19. Copie X, Hnatkova K, Staunton A, et a l. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. J Am Coll Cardiol 1996; 27: 270-6
20. Task Force of the European Society of Cardiology and the North American Society of Pacing. and Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043-65
21. Tsuji H, Larson MG, Venditti FJ Jr, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996; 94: 2850-5
22. Kleiger R E, Stein P K, Bigger J T Jr. Heart rate variability: Measurement and clinical utility. Ann Noninvasive Electrocardiol 2005; 10: 88-101
23. Liao D, Sloan RP, Cascio WE, et al. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 1998; 21: 2116-22
24. Gianaros PJ, Salomon K, Zhou F, et al. A greater reduction in high-frequency heart rate variability to a psychological stressor is associated with subclinical coronary and aortic calcification in postmenopausal women. Psychosom Med 2005; 67: 553-60
25. Huikuri HV, Jokinen V, Syvanne M, et al. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1999; 19: 1979-85
26. Lauer M S. Autonomic function and prognosis. Cleveland Clin J Med 2009; 76: S18-22
27. Tsuji H, Venditti F J Jr, Manders E S, et a l. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 1994; 90: 878-83
28. Brockbank C L, Chatterjee F, Bruce S A, Woledge R C. Heart rate and its variability change after the menopause. Exp Physiol 2000; 85: 327-30
29. Earnest C P, Lavie C J, Blair S N, Church T S. Heart rate variability characteristics in sedentary postmenopausal women following six months of exercise training: The DREW study. PLoS One 2008; 3: E2288
30. Toscani M, Migliavacca R, Sisson de Castro JA, Spritzer PM. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: A pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome. Metabolism 2007; 56: 992-7
31. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 ; 42: 1206-52
32. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-5
33. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-19
34. Wiltgen D, Benedetto I G, Mastella L S, Spritzer P M. Lipid accumulation product index: A reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod 2009; 24: 1726-31
35. Di Domenico K, Wiltgen D, Nickel F J, et a l. Cardiac autonomic modulation in polycystic ovary syndrome: Does the phenotype matter? Fertil Steril 2012 Sep 28. pii: S0015-0282(12)02137-1. doi: 10.1016/j.fertnstert.2012. 08.049. Epub ahead of print
36. Polanczyk CA, Rohde LE, Moraes RS, et al. Sympathetic nervous system representation in time and frequency domain indices of heart rate variability. Eur J Appl Physiol Occup Physiol 1998; 79: 69-73
37. Renaud P, Blondin J P. The stress of Stroop performance: Physiological and emotional responses to color-word interference, task pacing, and pacing speed. Int J Psychophysiol 1997; 27: 87-97
38. Delaney J P, Brodie D A. Effects of short-Term psychological stress on the time and frequency domains of heart-rate variability. Percept Mot Skills 2000; 91: 515-24
39. MacLeod CM. Half a century of research on the Stroop effect: An integrative review. Psychol Bull 1991; 109: 163-203
40. Windham BG, Fumagalli S, Ble A, et al. The relationship between heart rate variability and adiposity differs for central and overall adiposity. J Obes 2012; 2012: 149516
41. Antelmi I, de Paula RS, Shinzato AR, et al. Influence of age, gender, body mass index, and functional capacity on heart rate variability in a cohort of subjects withouTheart disease. Am J Cardiol 2004; 93: 381-5
42. Acharya U R, Kannathal N, Sing O W, Ping L Y, Chua T. Heart rate analysis in normal subjects of various age groups. Biomed Eng Online 2004; 3: 24
43. Ribeiro T F, Azevedo G D, Crescencio J C, et a l. Heart rate variability under resting conditions in postmenopausal and young women. Braz J Med Biol Res 2001; 34: 871-7
44. De Meersman RE, Stein PK. Vagal modulation and aging. Biol Psychol 2007; 74: 165-73
45. Liu CC, Kuo TB, Yang CC. Effects of estrogen on gender-related autonomic differences in humans. Am J Physiol Heart Circ Physiol 2003; 285: H2188-93
46. Chao H T, Kuo CD, Su YJ, et al. S hort-Term effect of transdermal estrogen on autonomic nervous modulation in postmenopausal women. Fertil Steril 2005; 84: 1477-83
47. Fernandes EO, Moraes RS, Ferlin EL, Wender MC, Ribeiro JP. Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: Results of a randomized, placebo-controlled trial with two regimens. Pacing Clin Electrophysiol 2005; 28: S172-7
48. Zuanetti G, Neilson JM, Latini R, et al. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell Infarto Miocardico. Circulation 1996; 94: 432-6
49. Walsh D, Nelson KA. Autonomic nervous system dysfunction in advanced cancer. Support Care Cancer 2002; 10: 523-8
50. Fadul N, Strasser F, Palmer JL, et al. The association between autonomic dysfunction and survival in male patients with advanced cancer: A preliminary report. J Pain Symptom Manage 2010; 39: 283-90
51. Hildreth C M. Prognostic indicators of cardiovascular risk in renal disease. Front Physiol 2011; 2: 121
52. Liao D, Cai J, Brancati FL, et al. Association of vagal tone with serum insulin, glucose, and diabetes mellitus-The ARIC Study. Diabetes Res Clin Pract 1995; 30: 211-21
53. Perini R, Milesi S, Fisher N M, Pendergast DR, Veicsteinas A. Heart rate variability during dynamic exercise in elderly males and females. Eur J Appl Physiol 2000; 82: 8-15
54. Colpani V, Oppermann K, Spritzer P M. Association between habitual physical activity and lower cardiovascular risk in pre-, peri-And postmenopausal women: A population-based study. Menopause 2012 Nov 19. Epub ahead of print
55. Lee D C, Sui X, Church T S, Lavie C J, Jackson A S, Blair SN. Changes in fitness and fatness on the development of cardiovascular disease risk factors hypertension, metabolic syndrome, and hypercholesterolemia. J Am Coll Cardiol 2012; 59: 665-72
56. Mesch VR, Siseles NO, Maidana P N, et al. Androgens in relationship to cardiovascular risk factors in the menopausal transition. Climacteric 2008; 11: 509-17
57. Coviello A D, Legro R S, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 2006; 91: 492-7
58. Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: A consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 2010 ; 95: 2038-49
59. Wiltgen D, Spritzer PM. Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes. Fertil Steril 2010; 94: 2493-6
60. Patel SM, Ratcliffe SJ, Reilly MP, et al. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2009; 94: 4776-84
61. Maturana MA, Spritzer PM. Association between hyperinsulinemia and endogenous androgen levels in peri-And postmenopausal women. Metabolism 2002; 51: 238-43
62. Maturana MA, Rubira MC, Consolim-Colombo F, Irigoyen MC, Spritzer PM. Androgenicity and venous endothelial function in post-menopausal women. J Endocrinol Invest 2010; 33 : 239-43
63. Kaye S A, Folsom A R, Soler J T, Prineas R J, Potter J D. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol 1991; 20: 151-6
64. Liedtke S, Schmidt ME, Vrieling A, et al. Postmenopausal sex hormones in relation to body fat distribution. Obesity (Silver Spring) 2012; 20: 1088-95
65. Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: The Study of Women's Health Across the Nation. Arch Intern Med 2008; 168: 1568-75
66. Elbers J M, Giltay E J, Teerlink T, et al. E ffects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol (Oxf) 2003; 58: 562-71
67. Wildman RP, Tepper PG, Crawford S, et al. Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from The Study of Women's Health Across the Nation. J Clin Endocrinol Metab 2012; 97: E1695-704